Literature DB >> 27752052

Immunotherapy: Novel modified T cells enable more-specific tumour targeting.

Peter Sidaway.   

Abstract

Entities:  

Year:  2016        PMID： 27752052     DOI： 10.1038/nrclinonc.2016.169

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

2.  Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors.

Authors:  Kole T Roybal; Jasper Z Williams; Leonardo Morsut; Levi J Rupp; Isabel Kolinko; Joseph H Choe; Whitney J Walker; Krista A McNally; Wendell A Lim
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.